C2C4C: A grand finish in Brussels

27/09/22     

With 150 riders from over 16 countries, the Country 2 Country 4 Cancer returned to Europe with a bang! For the 7th year running, the riders started their incredible journey on the 2nd of September in Munich, Germany, and finished 18 days later on the iconic Muur van Geraardsbergen, just West of Brussels in Belgium, covering nearly 3,000 kilometres (approximately 1,900 miles).

2022 C2C4C Rides map

Representing the UK&I team were The Coastbusters, Kirsty Pegram, Sarah Tedford, Laura Clark, Nish Soni, John Ryan, Kevin Pollock and Andrew Dennis; eight novice riders who went through six months of intensive training and peddled through the last segment of the ride with epic landscapes from Paris to Brussels in just three days.

This event is more than just a bike ride. For many, the motivation to participate in and advance cancer research is personal. Some are riding in honour of those who have lost their lives from cancer or are currently battling the disease. Others are survivors themselves.

The goal of C2C4C is to raise awareness for cancer research and European cancer organisations that are members of the Union for International Cancer Control. And this year, The Coastbusters raised an amazing £33,000 (as of 23 September) for Maggie's Cancer Centre and the Irish Cancer Society in its mission to support cancer patients in the UK and Ireland.

Irish Cancer Society

There are around 375,000 new cancer cases in the UK every year, that's around 1,000 every day.1 We’ve all seen first-hand too many times the devastation a cancer diagnosis has caused to family and friends. The funds raised will aid these two amazing charities to offer much-needed practical and emotional support to help people comprehend this news, manage their challenges and regain a sense of control.

“Cancer has impacted and taken away members of my family, friends and neighbours. I know how important and valued support provided by organisations like Maggie’s and the Irish Cancer Society is. With the recent news of a friend’s diagnosis, I am reminded yet again that there is an ever-present need for providing funding to continue these services," said Andrew Dennis, Director, Oral Product Development , UK&I, Bristol Myers Squibb.

A brief history
 

Nearly a decade ago, the first Coast 2 Coast 4 Cancer cycling event began with 53 employees riding 3,000 miles across the U.S. to honour loved ones impacted by cancer by raising funds for cancer research. Now in 2022, there are more than 350 participants from 23 countries, covering more than 6,000 miles for cancer.

Europe joined the efforts in 2016 with the first Country 2 Country 4 Cancer ride, and then colleagues in Japan debuted the Continent 2 Continent 4 Cancer ride in 2021. And 2022, welcomed colleagues from Latin America.

Collectively, the bike rides are known as C2C4C and have raised more than £10 million for cancer research worldwide benefiting charities that fund leading-edge cancer research in their region of the world.

"Our patients are at the heart of everything we do and the C2C4C campaign reflects this. Every year, we fully support all our employees who participate, as well as those who are encouraging and cheering on their colleagues. Their tenacity and spirit are a reflection of our commitment to cancer research,” said Scott Cooke, General Manager BMS UK&I, Bristol Myers Squibb.

2022 C2C4C Rides map

In the U.S., nine teams of riders will relay across the country from the 7th of September through the 3rd of October, starting in Cannon Beach, OR, making their way across the Rockies, and crossing the finish line in Long Branch, NJ, 27 days and nearly 3,000 miles from the start.

More than 65 employees from Latin America will alternate riding in Chile between Puerto Varas to Pucón for nearly 1,800 kilometres.

Finally, with seven teams of more than 70 employees, riders in Japan start on 22September in Makuhari, Chiba, and culminate 21 days later on 12th October in Otemachi, Toyko after nearly 2,100 kilometres.


References

1 Cancer Research UK: Cancer Statistics for the UK (cancerresearchuk.org). Last accessed: September 2022.

 

NO-GB-2200260
October 2022